The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Open accessAbstract
BACKGROUND: The potentially serious nature of herpes zoster (HZ) and the long-term complication post-herpetic neuralgia (PHN) are often underestimated. One in four people will contract herpes zoster in their lifetime, with this risk rising markedly after the age of 50 years, and affecting one in two in elderly individuals. Pain is the predominant symptom in all phases of HZ disease, being reported by up to 90% of patients. In the acute phase, pain is usually moderate or severe, with patients ranking HZ pain as more intense than post-surgical or labour pains. Up to 20% of patients with HZ develop PHN, which is moderate-to-severe chronic pain persisting for months or years after the acute phase. We review the available data on the effect of HZ and PHN on patients' quality-of-life. DISCUSSION: Findings show that HZ, and particularly PHN, have a major impact on patients' lives across all four health domains--physical, psychological, functional and social. There is a clear correlation between increasing severity of pain and greater interference with daily activities. Non-pain complications such as HZ ophthalmicus can increase the risk of permanent physical impairment. Some elderly individuals may experience a permanent loss of independence after an acute episode of HZ. Current challenges in the management of HZ and PHN are highlighted, including the difficulty in administering antiviral agents before pain becomes established and the limited efficacy of pain treatments in many patients. We discuss the clinical rationale for the HZ vaccine and evidence demonstrating that the vaccine reduces the burden of the disease. The Shingles Prevention Study, conducted among >38,000 people aged >or=60 years old, showed that the HZ vaccine significantly reduces the burden of illness and the incidence of both HZ and PHN. In the entire study population, zoster vaccination reduced the severity of interference of HZ and PHN with activities of daily living by two-thirds, as measured by two questionnaires specific to HZ. SUMMARY: A vaccination scheme may positively impact the incidence and course of HZ disease, thereby improving patients' quality-of-life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citationRowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Arvin, A. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.361 · Cited by 1,162
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869 · cited 1×
“Once established, the pain associated with HZ or PHN is difficult to treat [65].”
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Katz, J., & Melzack, R. (1999) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70381-9 · Cited by 723
Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy
Schmader, K. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211000-00002 · Cited by 550
Self-citationSabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., & Versavel, M. (2004) · Pain · doi:10.1016/j.pain.2004.01.001 · Cited by 527
Tyring, S., Barbarash, R. A., Nahlik, J. E., Cunningham, A., Marley, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00002 · Cited by 491
The measurement of pain; prototype for the quantitative study of subjective responses.
Beecher, H. K. (1957) · PubMed · Cited by 490
Backonja, M., Wallace, M. S., Blonsky, E. R., Cutler, B. J., Malan, P., Rauck, R., & Tobias, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70228-x · Cited by 424
Wood, M. J., Johnson, R. W., McKendrick, M. W., Taylor, J., Mandal, B. K., & Crooks, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301304 · Cited by 401
Self-citationAnalgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review
Hempenstall, K., Nurmikko, T. J., Johnson, R. W., A'Hern, R. P., & Rice, A. S. C. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020164 · Cited by 400
Self-citationRisk factors for postherpetic neuralgia in patients with herpes zoster
Jung, B. F., Johnson, R. W., Griffin, D. R. J., & Dworkin, R. H. (2004) · Neurology · doi:10.1212/01.wnl.0000123261.00004.29 · Cited by 373
Self-citationYoshikawa, T. T., & Schmader, K. (2001) · Clinical Infectious Diseases · doi:10.1086/320169 · Cited by 335
Self-citationWood, M. J., Kay, R., Dworkin, R. H., Soong, S. J., & Whitley, R. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.341 · Cited by 324
Aging, Immunity, and the Varicella–Zoster Virus
Arvin, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058091 · Cited by 307
Coplan, P. M., Schmader, K., Nikas, A., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., Bauer, M., Williams, H. M., Kaplan, K. M., et al. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2004.06.001 · Cited by 306
Self-citationAntiviral treatment for preventing postherpetic neuralgia
Chen, N., Li, Q., Yang, J., Zhou, M., Zhou, D., & He, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006866.pub3 · Cited by 289
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life
Katz, J., Cooper, E. M., Walther, R. R., Sweeney, E. W., & Dworkin, R. H. (2004) · Clinical Infectious Diseases · doi:10.1086/421942 · Cited by 258
Oster, G., Harding, G., Dukes, E., Edelsberg, J., & Cleary, P. D. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2005.01.359 · Cited by 246
Increased Risk of Stroke After a Herpes Zoster Attack: A Population-Based Follow-Up Study
Kang, J.-H., Ho, J.-D., Chen, Y.-H., & Lin, H.-C. (2009) · Stroke · doi:10.1161/strokeaha.109.562017 · Cited by 235
Risk Factors for Postherpetic Neuralgia
Choo, P. W. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1217 · Cited by 229
Opstelten, W. (2002) · Family Practice · doi:10.1093/fampra/19.5.471 · Cited by 228
Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia
Dworkin, R. H., Gnann, J. W., Oaklander, A. L., Raja, S. N., Schmader, K. E., & Whitley, R. J. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.10.008 · Cited by 211
Self-citationvan Wijck, A. J., Opstelten, W., Moons, K. G., van Essen, G. A., Stolker, R. J., Kalkman, C. J., & Verheij, T. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68032-x · Cited by 208
Edmunds, W. J., Brisson, M., & Rose, J. D. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00044-5 · Cited by 195
Management of herpes zoster (shingles) and postherpetic neuralgia.
Stankus, S. J., Dlugopolski, M., & Packer, D. (2000) · PubMed · Cited by 186
Vaccination against Herpes Zoster and Postherpetic Neuralgia
Oxman, M. N., Levin, M. J., & Shingles Prevention Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/522159 · Cited by 181
Herpes zoster ophthalmicus and the risk of stroke: A population-based follow-up study
Lin, H.-C., Chien, C.-W., & Ho, J.-D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d31e5c · Cited by 180
Varicella–Zoster Vaccine for the Prevention of Herpes Zoster
Kimberlin, D. W., & Whitley, R. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmct066061 · Cited by 169
Schmader, K. E., Sloane, R., Pieper, C., Coplan, P. M., Nikas, A., Saddier, P., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., et al. (2007) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318065b6c9 · Cited by 163
Self-citationHerpes zoster itch: preliminary epidemiologic data
Oaklander, A. L., Bowsher, D., Galer, B., Haanpää, M., & Jensen, M. P. (2003) · The Journal of Pain · doi:10.1016/s1526-5900(03)00637-0 · Cited by 158
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
van Hoek, A. J., Gay, N., Melegaro, A., Opstelten, W., & Edmunds, W. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.024 · Cited by 156
The burden of Herpes Zoster: A prospective population based study
SCOTT, F., Johnson, R., Leedham-Green, M., DAVIES, E., EDMUNDS, W., & Breuer, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.026 · Cited by 145
Self-citationCost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Hornberger, J. C., & Robertus, K. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-5-200609050-00004 · Cited by 143
de Melker, H. E., Berbers, G. A. M., Hahné, S., Rümke, H. C., van den Hof, S., de Wit, G. A., & Boot, H. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.017 · Cited by 138
The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
Schmader, K. E., Gnann, J. W., & Watson, C. P. N. (2008) · The Journal of Infectious Diseases · doi:10.1086/522152 · Cited by 135
Self-citationVaricella-Zoster Virus Eye Disease
Liesegang, T. J. (1999) · Cornea · doi:10.1097/00003226-199909000-00002 · Cited by 126
Herpes Zoster and Postherpetic Neuralgia: Optimizing Management in the Elderly Patient
Johnson, R. W., Wasner, G. L., Saddier, P., & Baron, R. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00002 · Cited by 124
Self-citationHerpes zoster and quality of life: A self-limited disease with severe impact
LYDICK, E. G., Epstein, R. S., Himmelberger, D. U., & White, C. J. (1995) · Neurology · doi:10.1212/wnl.45.12_suppl_8.s52 · Cited by 123
Stein, A., Britt, H. C., Harrison, C. M., Conway, E. L., Cunningham, A. L., & MacIntyre, C. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.012 · Cited by 121
Pasqualucci, A., Pasqualucci, V., Galla, F., Angelis, V. D., Marzocchi, V., Colussi, R., Paoletti, F. P., Girardis, M., Lugano, M., & Sindaco, F. D. (2000) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2000.440803.x · Cited by 120
The Impact of Chronic Diseases: The Partner's Perspective
Baanders, A. N., & Heijmans, M. (2007) · Family & Community Health · doi:10.1097/01.fch.0000290543.48576.cf · Cited by 120
Varicella-Zoster Virus: Virology and Clinical Management
(2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601194 · Cited by 115
van Seventer, R., Sadosky, A., Lucero, M. A., & Dukes, E. M. (2006) · Age and Ageing · doi:10.1093/ageing/afj048 · Cited by 105
Current Management of Herpes Zoster
Volpi, A., Gross, G., Hercogova, J. T., & Johnson, R. W. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506050-00005 · Cited by 103
Self-citationHerpes ZosterAntivirals and Pain Management
Pavan‐Langston, D. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.012 · Cited by 99
Postherpetic neuralgia in the elderly
Johnson, R. W., & McElhaney, J. E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02089.x · Cited by 90
Self-citationPhilip, A. G., & Thakur, R. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.9685 · Cited by 89
Is Donor Age an Important Determinant of Graft Survival?
Beck, R. W., Gal, R. L., Mannis, M. J., Holland, E. J., Cavanagh, H. D., Foulks, G. N., HECK, E. L., Lindquist, T., Macsai, M. S., Smith, R. E., et al. (1999) · Cornea · doi:10.1097/00003226-199909000-00001 · Cited by 85
Clinical and psychosocial correlates of post‐herpetic neuralgia
Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L., & Sabato, A. F. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21254 · Cited by 79
Post-Herpetic Neuralgia in Older Adults
Christo, P. J., Hobelmann, G., & Maine, D. N. (2007) · Drugs & Aging · doi:10.2165/00002512-200724010-00001 · Cited by 77
Severe complications of herpes zoster.
Volpi, A. (2007) · PubMed · Cited by 70
Herpes Zoster and Postherpetic Neuralgia in Older Adults
Schmader, K. E. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.003 · Cited by 69
Self-citationPrevention of herpes zoster and its painful and debilitating complications
Johnson, R. W., McElhaney, J. E., Pedalino, B., & Levin, M. J. (2007) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(07)60021-6 · Cited by 63
Self-citationHerpes Zoster in the Elderly: Issues Related to Geriatrics
Schmader, K. E. (1999) · Clinical Infectious Diseases · doi:10.1086/515205 · Cited by 55
Self-citationQuan, D., Hammack, B. N., Kittelson, J. K., & Gilden, D. H. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.noc60049 · Cited by 52
Weinke, T., Edte, A., Schmitt, S., & Lukas, K. (2010) · Journal of Public Health · doi:10.1007/s10389-010-0323-0 · Cited by 51
Self-citationMauskopf, J., Austin, R., Dix, L. P., & Berzon, R. A. (1994) · Quality of Life Research · doi:10.1007/bf00435395 · Cited by 50
Community and Patient Values for Preventing Herpes Zoster
Lieu, T. A., Ortega‐Sanchez, I. R., Ray, G. T., Rusinak, D., Yih, W. K., Choo, P. W., Shui, I. M., Kleinman, K., Harpaz, R., & Prosser, L. A. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826030-00006 · Cited by 45
Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., & Versavel, M. (2004) · Journal of Pain · doi:10.1016/j.jpain.2004.02.195 · Cited by 42
Vaccination to Prevent Herpes Zoster in Older Adults
Gnann, J. W. (2008) · Journal of Pain · doi:10.1016/j.jpain.2007.10.007 · Cited by 39
Manabe, H., Dan, K., Hirata, K., Hori, K., Shono, S., Tateshi, S., Ishino, H., & Higa, K. (2004) · Clinical Journal of Pain · doi:10.1097/00002508-200409000-00004 · Cited by 36
Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination
Johnson, R. W. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324909 · Cited by 34
Self-citationPavan‐Langston, D. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601194.016 · Cited by 8
Cited by
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 938
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
The specific disease burden of neuropathic pain: Results of a French nationwide survey
Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D. (2011) · Pain · doi:10.1016/j.pain.2011.09.014 · Cited by 427
Self-citationEfficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Schmader, K. E., Levin, M. J., Gnann, J. W., McNeil, S. A., Vesikari, T., Betts, R. F., Keay, S., Stek, J. E., Bundick, N. D., Su, S.-C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir970 · Cited by 430
Self-citationImmune ageing at single-cell resolution
Mogilenko, D. A., Shchukina, I., & Artyomov, M. N. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00646-4 · Cited by 381
Metadata
- Authors
- Johnson, R. W., Bouhassira, D., Kassianos, G., Leplège, A., Schmader, K. E., & Weinke, T.
- Venue
- BMC Medicine
- Published
- 2010-06-21
- Volume
- 8
- Issue
- 1
- Pages
- 37-37
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W2152734304
- Cited by
- 404
- References
- 73
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.